Justice Shelton-Mosley schools half of the Yale defense
Writing the season preview for Harvard always seems like a
bit of a waste of time. The Crimson have been the most consistently dominant
team in the Ivies for 20 years now, and it’s probably just safer and easier to assume
Harvard will go 10-0 or 9-1 and just call it a day. That’s true despite the
unusually large number of All Ivy players from last season who have graduated.
But for the sake of fan education, I will simply lay out the
most crucial things to know about the Crimson in bullet point form:
-Sophomore WR Justice Shelton is probably the best talented player
the Ivies have seen in a long while. I have no doubt he is NFL-bound. He was so
dominant at his position as a freshmen last year, I even think he might become
the first Ivy player to come out early and make himself eligible for the NFL
draft. He’s that good. Watch him.
-The starting QB will be Joe Viviano, unless his incredible
bad luck regarding injuries continues. Head Coach Tim Murphy says the job is up
for grabs, but Viviano is a super talent who’s more than earned his shot.
-Once again, Harvard has one of the easier schedules in the
Ivies, the one exception being having to travel to Penn to play their toughest
opponent of 2016. The Crimson couldn’t close the deal at home against Penn last
year and that cost them an undefeated season. It won’t be easier at Franklin
Field. Traveling to Princeton and Dartmouth may be slightly daunting
considering how surprising those two teams are this year.
-Because of all the stars who graduated, Harvard will
probably flood the news with lots of “breakout” players who dominate the Ivy
stat boards. The Crimson’s Harvard-name-powered recruiting advantage is just
that good. Don’t underestimate it.
What a Comeback
And speaking of Harvard, a former Harvard football player
who had to leave the team to fight cancer, is coming back to college football at
age 24 for one more year… to play for Michigan! That’s the incredible story ofMichael Hirsch, told today on the Harvard website.
No comments:
Post a Comment